Article Details

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M - BioSpace

Retrieved on: 2025-04-15 13:21:35

Tags for this article:

Click the tags to see associated articles and topics

Merck Eyes Oral Peptide Delivery With Cyprumed Deal Worth up to $493M - BioSpace. View article details on hiswai:

Excerpt

... biotech Cyprumed in a bid to make its peptide drugs orally available. ... peptides, including GLP-1 analogs, mini-proteins and macrocycles. Under ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo